Preclinical PET imaging study of lung cancer with 64CuCl2.
Qiang WangDongli SongXiaowei MaXiaodong WuLei JiangPublished in: Annals of nuclear medicine (2020)
The expression of CTR1 in human lung cancer xenograft model could be successfully visualized by 64CuCl2 PET examination. With the expected growth of PET/CT examination to be an essential strategy in clinical lung cancer management, 64CuCl2 has the potential to be a promising PET imaging agent of lung cancer.